Eva Van Overmeire, PhD

Eva joined the Life Sciences team of Korys in 2022. She is a board member at Ona Therapeutics, Commit Biologics and Astrivax. Prior to Korys, she was a Director within the Corporate Development & Finance department at UCB. Eva began her career in management consulting at McKinsey & Company, where she spent four years advising clients across Pharma, Medtech and Biotech. She holds a PhD in Immunology from VIB-VUB.